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Medizinischer Honig in der Wundbehandlung: antibakterielle
Eigenschaften
Abstract
Honey is an ancient wound treatment that was re-introduced into
modern medical practice in Australasia and Europe following the devel-
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opment of regulated wound care products. Its therapeutic properties
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are attributed to its antimicrobial activity and its ability to stimulate
rapid wound healing. This review will briefly describe the evidence that
demonstrates its antimicrobial activity in vitro and in vivo.
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Zusammenfassung
Honig wird von alters her als Mittel zur Wundbehandlung eingesetzt
und wurde in den letzten Jahrzehnten in Australien, Neuseeland und
schließlich auch in Europa wieder in das Spektrum der professionellen
antibakteriellen Wundtherapie eingeführt. Der therapeutische Nutzen
der Anwendung von medizinischem Honig beruht auf seiner antibakte-
riellenAktivitätundseinerFähigkeit,dieWundheilungzubeschleunigen.
Diese Übersicht beschreibt in vitro und in vivo Belege für die antibakte-
rielle Aktivität des medizinischen Honigs.
Schlüsselwörter:Honig,professionelleWundbehandlung,antibakterielle
Aktivität
Introduction
Honey is a sweet, sticky substance that is produced by
bees following the collection of nectar and honeydew. It
hasbeenhighlyprizedbymanforthousandsofyearsnot
only as a foodstuff, but as a sacred material and as a
medicine. The earliest record of its use in a wound treat-
mentisaninscriptiononafragmentofaclaytabletdated
to approximately 4500 years ago that described a recipe
for an ointment. Although honey was used widely in
treating wounds by ancient civilizations and it is still util-
ised in remote communities, it fell into disuse in modern
medicineduringthe1970s.Itsre-introductiondepended
upon the development of wound care products that
achieved approval by regulatory authorities, and its ac-
ceptance rested on evidence of clinical efficacy. The first
modernproducttogainregulatorystatuswasMedihoney.
It was licensed as a complementary therapy by the Aus-
tralian Therapeutic Groups Administration in 1999 and
has since become CE marked and is being used in
Europe. In the UK the first CE marked wound dressing to
gaindrugtariffstatusin2004wastulleimpregnatedwith
active manuka honey. A range of honey wound care
products are now available throughout Europe, Australia
and New Zealand and some are expected to be intro-
duced into North America. Much anecdotal evidence
supports the use of honey in treating wounds and the
extent of clinical evidence is often under-estimated [1].
Essentiallythebenefitsofhoneycanbroadlybesummar-
isedbyitsantimicrobialeffectsanditsinfluenceonrates
of healing. The former effects will be addressed in this
review.
The evaluation of the potency of
honeys
The antimicrobial nature of all honeys is clearly demon-
strated by the ability to remain unspoiled by micro-organ-
isms despite prolonged storage at room temperature. Its
high sugar content, low water content and acidity [2]
provide unsuitable conditions to promote the growth of
micro-organisms. Some honeys, however, possess addi-
tionalantimicrobialfactorsthataredetectableondilution
[3]. A survey of 345 New Zealand honeys employed an
agar diffusion assay to characterise the nature of this
activityandtodividehoneysintothreedistinctcategories:
those that did not produce zones of inhibition on dilution
during the assay, those whose zones of inhibition were
removed in the presence of catalase (an enzyme that
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zonesofinhibitioninthepresenceofcatalase[4].Hence
honeys were divided into those whose activity was con-
fined to their high sugar content, low moisture content
andacidity,orthosethatexclusivelygeneratedlowlevels
of hydrogen peroxide on dilution, or those that retained
activitythatwasindependentofthesynthesisofhydrogen
peroxideondilution.Thelattertwohoneysweredescribed
as peroxide honeys or non-peroxide honeys, respectively.
Theabilitytogeneratehydrogenperoxidehasbeenshown
to be due to the oxidation of glucose by glucose oxidase,
which is an enzyme secreted by the bee as it deposits
nectar and honeydew into the hive [5]. Peroxide honeys
arenotuncommon:aninvestigationintotheantibacterial
activity of 42 Canadian honeys against two bacterial
species, for example, showed that all possessed activity
that was associated with the production of hydrogen
peroxide [6].
Non-peroxidehoneys,however,arelesscommon.Manuka
honey from New Zealand and jelly bush honey from Aus-
tralia are two examples of non-peroxide honeys which
arepostulatedtopossessunidentifiedactivecomponents
in addition to the production of hydrogen peroxide [3].
Samples of such honeys that demonstrate activity in the
above assay have been recommended for utilisation in
modern wound care products [7]. Additionally, honeys
selected for medicinal use should be produced under
hygienicconditions,fromtraceablesources,withminimal
contaminationbypesticides,antibioticsorpollutants[8].
The inhibition of micro-organisms
by honey in laboratory tests
Many studies illustrating the antimicrobial activity of
honey have been published [3], [9], and at least 80 spe-
cies have been shown to be inhibited by honey. The dif-
fering methodology and the variety of honey samples
tested,however,provideinconsistentdataonthesuscept-
ibility of specific micro-organisms. In relation to wounds,
the sensitivity to honey of bacteria capable of causing
infection has been investigated in New Zealand [10], the
United Arab Emirates [11] and in Australia [12]. In our
laboratory we have tested cohorts of clinical isolates de-
rivedfrominfectedwoundstodemonstratesusceptibility
to active manuka honey [13], [14], [15]; using a sugar
syrup solution containing the four main sugars found in
honey,wehaveshownthattheinhibitionofstaphylococci,
enterococciandpseudomonadsinlaboratorytestsisnot
attributable to these sugars alone. It has also been
demonstrated that antibiotic-sensitive strains and their
respectiveantibiotic-resistantstrainsareequallysuscept-
ible to active manuka honey [13], [14], [15], [16]. Not
only are antibiotic resistant bacteria inhibited by honey,
but the synergistic action of honey and antibiotics has
been reported [17]. Fungal wound pathogens [18], [19]
and protozoa are also inhibited by honey [20].
The efficacy of honey in the
eradication of bacteria from
wounds
The inhibition of microbial species by honey in vivo has
the potential to clear infection, remove malodours and
prevent cross-infection [1]. Much clinical evidence has
beenpublishedtosupporttheuseofhoneyinenhancing
wound healing [1]; the number of patients included in
published studies now exceeds 2000. One of the most
interesting observations on the clinical use of honey has
been its success in eradicating methicillin-sensitive Sta-
phylococcus aureus (MRSA) from colonised chronic
wounds [21], [22], [23], [24], [25]. It has been used
successfully on a diabetic foot ulcer in a patient who was
threatened with amputation [25] and it has become a
first-line treatment in at least one surgical unit [23], in-
stead of the one of last resort.
Conclusion
Honeyisabroadspectrumantimicrobialagentofvarying
potency, but honeys suitable for wound treatment can
bereadilyselectedbyanagarwelldiffusionassay.Honey
has a complex chemical composition and neither the
identities of all of its inhibitory components nor its
mechanisms of action are yet completely understood.
Laboratory tests have demonstrated the effective inhibi-
tion of a wide range of microbial species, with both anti-
biotic-sensitive and antibiotic-resistant bacteria showing
susceptibility. The publication of case reports of the
eradication of MRSA from patients give validity to in vitro
observations, but large scale clinical trials are needed to
establish its clinical efficacy. With the increased availab-
ility of licensed wound care products containing honey,
clinical use is expected to increase and further evidence
willbecomeavailable.Honeyseemstohavethepotential
toclearinfectionaswellasbeinganeffectiveprophylactic
agent that may contribute to reducing the risks of cross-
infection. Time will demonstrate whether the present
optimism about honey is justified.
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